ATE176155T1 - Injizierbare amphotericin b enthaltende dispersion - Google Patents

Injizierbare amphotericin b enthaltende dispersion

Info

Publication number
ATE176155T1
ATE176155T1 AT91919697T AT91919697T ATE176155T1 AT E176155 T1 ATE176155 T1 AT E176155T1 AT 91919697 T AT91919697 T AT 91919697T AT 91919697 T AT91919697 T AT 91919697T AT E176155 T1 ATE176155 T1 AT E176155T1
Authority
AT
Austria
Prior art keywords
amphotericin
dispersion containing
containing amphotericin
injectable dispersion
injectable
Prior art date
Application number
AT91919697T
Other languages
English (en)
Inventor
Junzo Seki
Hirofumi Yamamoto
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE176155T1 publication Critical patent/ATE176155T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91919697T 1990-11-16 1991-11-15 Injizierbare amphotericin b enthaltende dispersion ATE176155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31205790 1990-11-16

Publications (1)

Publication Number Publication Date
ATE176155T1 true ATE176155T1 (de) 1999-02-15

Family

ID=18024709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919697T ATE176155T1 (de) 1990-11-16 1991-11-15 Injizierbare amphotericin b enthaltende dispersion

Country Status (6)

Country Link
US (1) US5776904A (de)
EP (1) EP0558750B1 (de)
JP (1) JP3074734B2 (de)
AT (1) ATE176155T1 (de)
DE (1) DE69130832T2 (de)
WO (1) WO1992008467A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291436B1 (en) 1999-07-16 2001-09-18 International Fiber Corporation Direct action anti-mycotic
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
KR100743404B1 (ko) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
KR20020062494A (ko) * 2001-01-22 2002-07-26 유봉규 단량체 폴리엔마크로리드계열 항생제를 함유한 고체분산체조성물
CA2500716A1 (en) * 2002-10-03 2004-04-15 University Of Mississippi Compositions comprising highly purified amphotericin b
JP2008503586A (ja) * 2004-06-21 2008-02-07 ネクター セラピューティクス アンフォテリシンｂを含む組成物、方法、およびシステム
US8513204B2 (en) * 2004-06-21 2013-08-20 Novartis Ag Compositions comprising amphotericin B, mehods and systems
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO2008063756A2 (en) * 2006-10-03 2008-05-29 Accentia Biopharmaceuticals, Inc. Mucosally non-irritative amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928570A (en) * 1971-11-29 1975-12-23 Squibb & Sons Inc Amphotericin complexes
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US4035567A (en) * 1975-10-21 1977-07-12 E. R. Squibb & Sons, Inc. Process for producing the methyl ester of amphotericin B
HU196230B (en) * 1983-12-29 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
FR2604903B1 (fr) * 1986-10-08 1989-01-13 Sopar Sa Nv Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
US4822777A (en) * 1987-02-27 1989-04-18 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition
US4950477A (en) * 1988-08-23 1990-08-21 Memorial Hospital For Cancer And Allied Dieseas Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes
EP0467954B1 (de) 1989-03-31 1996-05-01 The Regents Of The University Of California Zubereitung von liposomen- und lipid-komplexzusammensetzungen

Also Published As

Publication number Publication date
EP0558750A4 (en) 1993-10-20
EP0558750A1 (de) 1993-09-08
US5776904A (en) 1998-07-07
DE69130832D1 (de) 1999-03-11
WO1992008467A1 (fr) 1992-05-29
JP3074734B2 (ja) 2000-08-07
DE69130832T2 (de) 1999-10-07
EP0558750B1 (de) 1999-01-27

Similar Documents

Publication Publication Date Title
DE3853191D1 (de) Arzneimittelträger.
NO931710D0 (no) Fremgangsmaate for fremstilling av en stabil ikkeagglomerende, vandig suspensjon av et oljeopploeselig, polymert, friksjonsreduserende middel
DK0602702T3 (da) Anvendelse af tyloxapol som nanopartikelstabilisator og dispergeringsmiddel
ATE61582T1 (de) Styrylpyrazole, -isoxazole und analoga mit 5lipoxygenase-inhibitor-wirkung und pharmazeutische zusammensetzungen damit.
PL279333A1 (en) Emulsion or suspension emulsion of the oil in water type with pesticide action
ATE90718T1 (de) Haftklebrige flaechengebilde.
ATE176155T1 (de) Injizierbare amphotericin b enthaltende dispersion
FI906328A0 (fi) En anordning foer kontrollerad administrering av aktiva aemnen i ett funktionerande medium.
DE69202892D1 (de) Föttinger Kupplung mit fester Flüssigkeitsmenge und Haupt- und Hilfsverzögerungskammer.
ATE112584T1 (de) Mit isocyanat reagierende zusammensetzungen.
Poch Fabric and physical properties of soils with Gypsic and Hipergypsic horizons of the Ebro Valley
DE3671429D1 (de) Augenselektive betablockierende und diese enthaltende zusammensetzungen.
IT8805215A0 (it) Girello per bambini con sistema di arresto in presenza di gradini o dislivelli.
Jarrett Personality and artistic creativity
FR2711320B1 (fr) Canule de calage et d'écartement.
FR2642723B1 (fr) Dispositif d'ancrage avec piece de stabilisation
AU573782B2 (en) Hardly inflammable, biologically degradable functional liquid
Zeng Discussion on the formulas of gas transportation and hydraulic frictional drag coefficient
Hentschel Expectations and perceptions of the wilderness travel experience
Wang Stoichiometric interactions of atrazine and hydroxyatrazine with chemically-characterized laurentian soil and its key components
NO930275D0 (no) Vandige polymerisatpreparater, samt fremstilling og anvendelse
Bunce et al. Ecological consequences of land use change. Final report
Noreuil Improving the administration of 911
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
Perry Creativity and Routine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties